Mirum Pharmaceuticals Inc investor relations material

Mirum Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company was founded with the goal of developing drugs that can address unmet medical needs. It has developed two lead candidates. These two therapies are designed to treat patients suffering from rare genetic disorders that affect their metabolism, such as phenylketonuria (PKU).